The HPA Axis — Three Glands, One System
The hypothalamic-pituitary-adrenal axis is a three-tier hormonal cascade that coordinates the body’s response to stress — physical, psychological, inflammatory, or metabolic. The three components communicate through a sequential chemical signalling chain: the hypothalamus instructs the pituitary, the pituitary instructs the adrenal glands, and the resulting cortisol output feeds back to both the hypothalamus and pituitary to regulate its own production. This feedback loop is the central regulatory mechanism — and its failure is the mechanism of HPA axis dysfunction.
The hypothalamus is the integrating centre — it receives input from the cerebral cortex (conscious thought, worry, anticipation), the limbic system (emotional processing, memory, the amygdala’s threat assessment), the brainstem (physiological signals from the body), and the circadian system (time of day via the suprachiasmatic nucleus). All of these inputs converge on the paraventricular nucleus (PVN) of the hypothalamus, which synthesises and releases corticotrophin-releasing hormone (CRH) in response to perceived demand.
CRH travels through the hypothalamic-portal blood system to the anterior pituitary, where it binds to CRH receptors on corticotroph cells, stimulating the synthesis and release of adrenocorticotrophic hormone (ACTH). ACTH is released into the systemic circulation and travels to the adrenal glands.
The adrenal glands — small, pyramid-shaped glands sitting atop each kidney — respond to ACTH at the zona fasciculata of the adrenal cortex, stimulating cholesterol mobilisation from lipid droplets and the enzymatic cascade that converts cholesterol to cortisol via pregnenolone, progesterone, and 17-hydroxyprogesterone. The entire sequence from hypothalamic CRH to circulating cortisol takes approximately 15–30 minutes in an acute stress response.
Pregnenolone is the master steroid precursor — the starting material from which all steroid hormones are synthesised. Under chronic stress, the adrenal demand for cortisol production diverts pregnenolone preferentially toward the cortisol synthesis pathway. This reduces the pregnenolone available for DHEA, testosterone, oestrogen, and progesterone synthesis.
This is the mechanistic basis for the pattern frequently seen in chronically stressed individuals: low progesterone, low DHEA-S, declining testosterone, reduced oestradiol — all occurring simultaneously not because of primary gonadal failure but because the adrenal gland has first claim on the precursor pool. The DUTCH Plus makes this visible: low DHEA metabolites alongside high cortisol metabolites in the same report is the pregnenolone steal pattern.
Cortisol Synthesis and Metabolism — What the DUTCH Measures
Cortisol circulates in two forms: approximately 90–95% is bound to corticosteroid-binding globulin (CBG) and albumin — physiologically inactive, a circulating reservoir. The remaining 5–10% is free cortisol — the bioavailable fraction that enters cells, binds glucocorticoid receptors, and produces biological effects. Standard blood cortisol tests measure total cortisol (bound + free), which is primarily a measure of CBG levels rather than bioavailable cortisol. This is why blood cortisol is an unreliable indicator of functional cortisol status — oestrogen significantly raises CBG, increasing total cortisol without increasing free cortisol. The DUTCH measures free cortisol in urine, providing a direct measure of bioavailable cortisol output.
Cortisol is metabolised primarily in the liver by two enzymes: 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active cortisol from inactive cortisone in peripheral tissues — particularly important in adipose tissue, liver, and brain where local cortisol concentrations are regulated independently of circulating levels. 11β-HSD2 converts active cortisol to inactive cortisone — a protective mechanism in tissues like the kidney that should not be exposed to glucocorticoid signalling continuously.
The metabolised forms — the “spent” cortisol and cortisone after they have been reduced and conjugated by the liver — appear in urine as tetrahydrocortisol (THF), allo-THF, and tetrahydrocortisone (THE). The DUTCH measures these metabolites as the total metabolised cortisol output — the most complete picture of the body’s total 24-hour cortisol production available from a non-invasive test. High total metabolised cortisol with normal free cortisol indicates high production but efficient clearance. High free cortisol with lower metabolites indicates reduced clearance. Low everything indicates reduced production — the late-stage burnout pattern.
Elevated urinary cortisone relative to cortisol (as in the pattern described in the constipation post — saliva cortisone 64, range 36–55) indicates that 11β-HSD2 is actively converting excess cortisol to cortisone across tissues. The body is producing more cortisol than its receptor sensitivity can comfortably manage and is attempting to inactivate the excess. This is early-stage HPA axis overactivation — the system is working hard but is beginning to protect peripheral tissues from cortisol overexposure through enzymatic inactivation.
The Cortisol Awakening Response — The Most Informative 60 Minutes of the Day
The cortisol awakening response (CAR) is a discrete, specific component of the diurnal cortisol rhythm — distinct from the overall morning rise. It is a rapid 50–100% surge in cortisol that occurs in the first 20–30 minutes after waking, triggered by the environmental cue of light exposure and the circadian transition from sleep to wakefulness through the hypothalamic suprachiasmatic nucleus.
The CAR is not simply “high morning cortisol.” It requires four measurements at specific time points to capture properly: immediately on waking (0 minutes), at +15 or +30 minutes (the peak), and declining measurements at +45 and +60 minutes. The magnitude of the rise from waking to peak is the CAR. A healthy CAR represents a 50–100% increase from the waking value. The DUTCH Plus captures this through four timed saliva samples taken by the client on the morning of collection.
The CAR has distinct physiological functions. It primes the immune system for the day — mucosal sIgA production is partially dependent on the morning cortisol surge, which is why depleted sIgA on the GI-MAP and a blunted CAR on the DUTCH frequently co-occur. It mobilises glucose for cognitive function — the early morning blood glucose rise is partially cortisol-driven. It prepares the cardiovascular system — heart rate and blood pressure peak in the early morning partly through the CAR. It regulates inflammatory tone for the day ahead.
The CAR also reflects the brain’s anticipatory assessment of the day’s demands. People with high work demands, high perceived stress, or significant anticipatory anxiety show consistently exaggerated CARs — the HPA axis is preparing for a day it expects to be difficult. Shift workers, people with circadian misalignment, burnout, PTSD, and chronic fatigue syndrome all show significantly disrupted CAR patterns. The CAR is not measuring how stressed someone is in that moment — it is measuring how responsive the HPA system is, which is a different and more informative clinical question.
Strict timing is mandatory. The client must take the first sample the moment they wake — before getting up, before drinking anything, before checking their phone. Any delay of even 10 minutes significantly distorts the waking value and therefore the calculated CAR magnitude.
Workday collection preferred for most clients. A day off produces a different CAR than a workday — lower anticipatory arousal, later waking time, reduced perceived demand. The workday CAR is more clinically representative of habitual HPA activation patterns.
Alarm vs natural waking. Alarm-waking produces a more exaggerated CAR than natural waking — the abrupt transition creates a larger acute cortisol response. If the client always uses an alarm, alarm-waking collection is more representative of their typical pattern.
The Diurnal Pattern — Reading the Full Day
After the CAR, cortisol follows a predictable diurnal decline — high in the morning (typically peaking 30–45 minutes after waking), declining progressively through the morning, reaching a mid-point in early afternoon, and falling to its lowest point in the hours before midnight. This diurnal rhythm is driven by the circadian clock in the suprachiasmatic nucleus and is the physiological basis for the advice to align the most cognitively demanding work with the morning cortisol window.
The DUTCH Plus provides four saliva cortisol measurements across the day (waking, +30 minutes, afternoon, evening) plus the metabolised cortisol from the urine collection. This gives both the pattern (the four-point diurnal shape) and the total output (the 24-hour metabolised cortisol sum). Both are clinically necessary — a person with a flat, low diurnal pattern but high total metabolised cortisol has a different clinical picture from a person with a dramatically high morning spike and rapid afternoon crash.
Elevated evening cortisol — the clinical consequence
Elevated cortisol in the evening window (the third or fourth DUTCH saliva sample) is one of the most clinically consequential single findings on the DUTCH. Evening cortisol elevation directly suppresses melatonin secretion from the pineal gland — melatonin synthesis requires darkness and low cortisol, as the two are physiologically antagonistic. Elevated evening cortisol therefore produces delayed sleep onset, fragmented sleep architecture, and reduced delta wave deep sleep. The person lies awake with a busy mind — a direct neurological consequence of cortisol’s arousal effects on the locus coeruleus and prefrontal cortex — not a psychological habit of worrying. The sleep disruption then drives morning fatigue, impairs the cortisol clearance that occurs during deep sleep, and perpetuates elevated evening cortisol the following night. The cycle is self-reinforcing.
Elevated evening cortisol is not “stress.” It is a specific hormonal state with documented neurological consequences — melatonin suppression, locus coeruleus activation, impaired prefrontal inhibition of the default mode network. The person is not choosing to lie awake thinking. Their cortisol is keeping them awake.
The Burnout Trajectory — Four Stages from Overactivation to Depletion
HPA axis dysfunction does not appear suddenly. It follows a trajectory that, in most people, develops over months to years through predictable stages. Understanding the stage is the most clinically important single piece of information from the DUTCH — because the intervention at Stage 1 is diametrically different from the intervention at Stage 4, and applying the wrong intervention at the wrong stage produces either no response or an adverse response.
Stage 1 and Stage 2 respond to interventions that regulate the overactive HPA axis downward — phosphatidylserine, ashwagandha, adequate sleep, reducing stimulants, VILPA to metabolise cortisol load.
Stage 3 and Stage 4 require the opposite approach: gentle adrenal support, caloric adequacy (the HPA axis cannot produce cortisol without adequate substrate — severe restriction worsens Stage 3/4), rest rather than exercise, adaptogenic support that is tonifying rather than stimulating, and addressing all the downstream consequences of prolonged cortisol insufficiency (thyroid conversion, immune function, gut motility) concurrently. Prescribing ashwagandha at high dose to a Stage 4 burnout can produce worsening of symptoms.
Always identify the stage before prescribing the intervention. The DUTCH is not optional for this assessment — clinical symptoms alone are insufficient to differentiate Stage 1 from Stage 4.
Downstream Consequences — What Cortisol Dysregulation Drives
Immune suppression and gut vulnerability
Glucocorticoid receptors are present on virtually every immune cell type. Cortisol at chronically elevated levels suppresses Th1 immune function (cellular immunity, viral defence), promotes Th2 dominance (allergic and antibody responses), and reduces secretory IgA production at mucosal surfaces. The practical consequence: the chronically stressed person is more susceptible to viral infections, develops more food sensitivities (as reduced sIgA allows antigens to reach the gut immune system that would normally be neutralised in the lumen), and shows progressively worsening gut dysbiosis as mucosal immunity becomes inadequate to maintain commensal ecology.
Insulin resistance and metabolic consequences
Covered in detail in Study Guide 01 (Insulin Resistance). Briefly: cortisol drives hepatic gluconeogenesis, promotes adipocyte lipolysis, and directly impairs peripheral insulin receptor signalling. The DUTCH CAR magnitude is one of the best available predictors of fasting insulin elevation and HOMA-IR trajectory — a person with a 67% CAR is driving morning hepatic glucose output that precedes the first meal of the day and sets the insulin tone for the morning.
Thyroid conversion impairment
Covered in Study Guide 02 (Thyroid Conversion). Cortisol at elevated levels upregulates type 3 deiodinase (T4 → reverse T3) and downregulates type 1 deiodinase (T4 → T3). The combination of high cortisol output and impaired T3 production produces the tissue hypothyroidism pattern — fatigue, cold intolerance, weight gain, brain fog — with normal TSH and borderline Free T4. The DUTCH CAR sits upstream of the thyroid conversion problem in most cases of stress-related functional hypothyroidism.
Sex hormone disruption
Beyond the pregnenolone steal, elevated cortisol directly suppresses gonadotrophin-releasing hormone (GnRH) from the hypothalamus, reducing LH and FSH from the pituitary and consequently reducing ovarian and testicular hormone production. The evolutionary logic: reproduction is not a priority during sustained threat. The clinical consequence in the modern context: low testosterone in men under chronic occupational stress, irregular cycles in women, anovulatory cycles, and worsening PCOS as the cortisol-insulin loop amplifies the androgen excess.
Gut motility — the sympathetic override
As described in detail in the constipation and gut motility clinical post: CRH from the hypothalamus reaches enteric mast cells directly via the HPA-enteric nervous system connection, triggering mast cell degranulation and modifying gut permeability and motility independently of circulating cortisol. The gut knows about stress through the nervous system before the adrenal glands have had time to respond. This is the mechanism behind stress-induced IBS, urgency with acute anxiety, and the chronic motility suppression of sustained sympathetic dominance.
Feedback Failure — Why the HPA Axis Loses Regulation
Under healthy physiology, rising cortisol feeds back to suppress its own production. Cortisol binds to glucocorticoid receptors in the hippocampus, the hypothalamus (reducing CRH release), and the anterior pituitary (reducing ACTH release). This negative feedback loop is the regulatory mechanism that prevents cortisol from rising indefinitely.
Under chronic stress, this feedback mechanism fails progressively through two concurrent mechanisms. First, glucocorticoid receptor downregulation: chronic cortisol exposure reduces the number and sensitivity of glucocorticoid receptors on hippocampal neurons and hypothalamic cells — the feedback signal becomes weaker as the receptor population shrinks. Second, hippocampal damage: cortisol at chronically elevated levels is directly neurotoxic to hippocampal CA3 neurons, reducing the hippocampal volume that normally constrains HPA axis activity. Chronic stress literally damages the brain region responsible for switching off the stress response. MRI studies of people with chronic burnout, PTSD, and major depression consistently show reduced hippocampal volume.
The clinical implication: early-stage HPA overactivation, if sustained for long enough, progressively impairs the feedback mechanism, making it harder for the axis to self-regulate regardless of the stressor load reducing. This is why people who have been in chronic stress for years do not simply recover when the external stressor resolves — the regulatory architecture itself has been compromised and requires specific intervention to restore feedback sensitivity.
Phosphatidylserine (PS) is the best-studied intervention for glucocorticoid receptor sensitisation. PS (300–800mg daily) has documented effects on cortisol response to psychological and physical stress in RCTs — blunting the ACTH response to CRH and reducing the cortisol overshoot to standardised stress protocols. The mechanism: PS is a structural component of neuronal cell membranes and improves glucocorticoid receptor function in hippocampal tissue. Particularly relevant at Stages 1 and 2.
Sleep is the primary mechanism of hippocampal restoration — deep sleep (delta wave, slow-wave sleep) is when hippocampal neurogenesis occurs and cortisol clearance is maximised. Addressing sleep architecture is therefore not a symptom-level intervention but a mechanism-level one for HPA feedback restoration. Melatonin (0.5–1mg, not the 5–10mg doses commonly used), magnesium glycinate (400mg evening), and phosphatidylserine together address the evening cortisol excess that is preventing deep sleep.
Omega-3 fatty acids (EPA 2–3g daily) reduce hypothalamic NF-κB activation, reducing CRH secretion and dampening the inflammatory drive to HPA axis activation that perpetuates the cycle in people with both chronic stress and gut-derived inflammation.
Interventions by Stage — The Most Important Clinical Distinction
Phosphatidylserine (Stage 1–2)
300–800mg daily. Most evidence at 400–800mg. Blunts CAR and reduces afternoon cortisol spike. Best taken in morning with food at Stage 1 (when reducing overall output is the goal) or split morning/evening at Stage 2.
Ashwagandha (Stage 1–2 only)
KSM-66 or Sensoril extract, 300–600mg daily. Multiple RCTs showing cortisol reduction and improved stress perception. Contraindicated at Stage 3–4 where it can overstimulate a depleted system. Always identify stage first.
Rhodiola (Stage 1–2)
Rosavin + salidroside extract. More activating than ashwagandha — better for Stage 1 fatigue without complete depletion. Take in the morning only — activating effects can worsen sleep if taken in the afternoon. Not for Stage 3–4.
Adrenal glandulars (Stage 3–4)
Bovine adrenal extract provides precursor support for depleted adrenal tissue. Clinical tradition rather than RCT evidence. Appropriate at Stage 3–4 where stimulating adaptogens are contraindicated. Must be accompanied by adequate caloric intake — substrate availability is rate-limiting at this stage.
Melatonin (all stages)
0.5–1mg 30–60 minutes before bed. The physiological dose — not the pharmacological 5–10mg doses commonly sold. Higher doses override rather than restore the melatonin rhythm. Works with phosphatidylserine and magnesium to reduce evening cortisol and restore sleep architecture.
VILPA / exercise snacks (Stage 1–2)
Very Intense Low-volume Physical Activity — 1–2 minute bouts of high-intensity movement 3–5 times daily. Metabolises circulating cortisol and adrenaline directly. Reduces background sympathetic tone. At Stage 3–4, gentle walking only — vigorous exercise at this stage increases cortisol demand on an already depleted system.
Vitamin C (Stage 3–4)
The adrenal glands are among the most vitamin C-rich tissues in the body — vitamin C is consumed during cortisol synthesis. At Stage 3–4 with depleted output, 1–2g daily vitamin C provides substrate support for the adrenal cortex. Reduces ACTH-stimulated cortisol response paradoxically while supporting baseline production.
B5 (pantothenic acid)
Pantothenic acid is a precursor of coenzyme A, required for cholesterol mobilisation in adrenal steroidogenesis. Depletion impairs the very first step of cortisol synthesis. 500–1000mg daily as part of Stage 3–4 support. Often combined with adrenal glandulars and B-complex.
What to Test — The Complete HPA Axis Assessment
Step 1: DUTCH Plus — complete HPA picture in one test. CAR (stage identification), total output (production capacity), free cortisol (bioavailability), cortisone (inactivation pattern), DHEA-S (adrenal reserve), melatonin (sleep impact). This is the non-negotiable assessment — no clinical HPA intervention should be made without it.
Step 2: GI-MAP sIgA — immune consequence of the adrenal pattern. Low sIgA with blunted CAR confirms the gut immune consequence and guides restoration sequencing.
Step 3: HTMA Na/Mg and Na/K — the 8–12 week adrenal mineral picture that contextualises the DUTCH snapshot. DUTCH tells you what is happening in 24 hours. HTMA tells you what has been happening over months.
Step 4: Blood chemistry — hsCRP (inflammatory driver), HOMA-IR (metabolic consequence), Free T3 (thyroid conversion consequence), ferritin (immune and adrenal substrate). These four blood markers complete the downstream consequence picture.
Always identify stage before prescribing. The DUTCH stage identification is the first clinical output from the assessment. Document it explicitly. Every intervention prescription follows from the stage — not from the symptoms alone.